Health:Further

Vic and Marcus discuss revised jobless claims, Nvidia's continued AI-driven growth, and major developments across healthcare, technology, and policy. They cover Cityblock's acquisition of Homeward Health, new telehealth prescribing rules, Meta's $17.1 billion settlement over teen social media protections, and Medicare overbilling allegations involving Humana-owned Villages Health. The episode also examines cyberattacks affecting medical device companies, a new FDA-approved treatment for pancreatic cancer, Alzheimer's blood testing, diabetes monitoring technology, and concerns about AI transparency in healthcare. They close with Nvidia's reported move to acquire Hugging Face, Stripe's OpenRouter acquisition, and warnings from major technology companies about the growing threat of...

Vic and guest host Paul Kappleman discuss the state of U.S. healthcare under the Trump administration, including access, affordability, hospital closures, consolidation, and the potential rise of Medicare for All. They examine weakening retail sales, interest rates, $40 trillion in U.S. debt, healthcare venture capital, at-home sleep apnea diagnosis, pancreatic cancer screening, primary care, FDA leadership and AI-enabled medical devices, Medicaid asset limits, Costco entering Medicare, Providence Health Plan's exit, and Moderna's personalized cancer vaccine. They also cover an exercise pill, patient access to test results, Bitcoin and the CLARITY Act, robotic blood draws, Epic's AI platform, OpenAI's...

Retail sales fell 0.6% in July. Inflation held steady at 3.4%. Jobless claims jumped to 209,000. Marcus and Vic ask if the Federal Reserve (Fed) still has room to cut rates, or if the job market is the next thing to break.

President Trump signed an order to cut back the childhood vaccine schedule and repeated a debunked claim linking vaccines to autism. Medical groups pushed back hard. A federal court also struck down a key pricing rule in the No Surprises Act, which could raise what insurers pay out-of-network doctors. Employers are dropping the three biggest pharmacy benefit managers...

Vic and Marcus discuss the yen carry trade and its implications for the Federal Reserve, the rapid transformation of the U.S. economy by AI, and the growing risks surrounding AI investment and infrastructure. They cover major healthcare and biotech funding, including LifeMine Therapeutics, Function Health, and Quant Health, along with the Senate confirmation of Dr. Erica Schwartz as CDC director and a 2.3% Medicare hospital payment increase for 2027. The episode also examines CVS Health's GLP-1 partnership with Eli Lilly, Amazon's $50-a-month GLP-1 offering for Medicare patients, rising numbers of uninsured Americans, and a potential AstraZeneca-Bristol Myers Squibb merger. They...

Vic and Marcus discuss the return of Trump's tariffs, the Federal Reserve's evolving approach under Chairman Warsh, and the continued strength of AI infrastructure as Microsoft and Amazon report surging cloud growth. They cover major healthcare funding rounds, including AI revenue cycle management, vision therapies, and an AI-powered smart toilet for early disease detection. The episode also examines FTC action against Hims & Hers, the end of Medicare drug plan subsidies, Medicaid work requirement rulings, payer earnings, ACA market instability, rising uninsured rates, hospital consolidation, biotech acquisitions, the Ebola outbreak in the Democratic Republic of Congo, new wearable health monitoring...

Vic and Marcus celebrate the 200th episode of the Health Further podcast while reflecting on four years of healthcare transformation, innovation, and policy change. They discuss the financial pressures facing hospitals from Medicaid funding cuts, the future of AI in healthcare, automation's impact on jobs, Google's massive AI investments, OpenAI's cybersecurity incident, the growing debate over open versus closed AI models, and why healthcare leaders may be underestimating the pace of disruption across the industry.

Story Lineup

8:35 -  Story 1: LA Safety-Net Hospital Braces for $80–100M Annual Medicaid Hit From HR 1 Cut...

Vic and Marcus discuss easing inflation, the growing number of workers locked out of the job market, and major venture funding rounds for AI-powered healthcare companies. They examine proposed Medicare physician payment cuts, prior authorization policy, Medicaid challenges, insurer earnings, and mounting financial pressure on hospitals as care continues shifting to outpatient settings. They also cover Eli Lilly's latest acquisition, a first-of-its-kind cholesterol pill, food safety concerns, new wearable health technology, Visa's stablecoin platform, AI agent commerce, and China's rapid advances in artificial intelligence that are reshaping global competition.

Story Lineup

Vic and Marcus discuss uncertainty around Federal Reserve interest rate policy, continued strength in AI infrastructure and semiconductor markets, and major venture funding across biotech and value-based care. They examine proposed NIH research policy changes, the impact of Medicaid enrollment reductions and rising ACA premiums, Medicare Advantage legal disputes, healthcare bankruptcies, labor strikes, and Ascension's acquisition of Williamson Health. They also cover major pharmaceutical acquisitions, expanding access to peptides, advances in brain-computer interfaces, the challenges of integrating wearable data into clinical care, blockchain's growing role in banking, China's evolving AI strategy, Apple's lawsuit against OpenAI, and the rapid expansion...

Vic and Marcus discuss slowing U.S. job growth, Meta's move into AI cloud infrastructure, record venture funding driven by AI, and what those trends mean for the technology sector. They examine Medicare coverage for weight loss drugs, proposed CMS changes affecting hospitals, Medicaid work requirement lawsuits, and the continued shift of care away from hospitals. They also cover major healthcare advances, including expanded gene therapy for children with sickle cell disease, AI-powered drug discovery partnerships, and the first FDA-approved Treg cell therapy. The episode concludes with the record-low U.S. death rate, stablecoin adoption, blockchain tokenization, and the...

Vic and Marcus discuss rising inflation, the AI-driven data center boom, and growing concerns about the long-term economic impact of artificial intelligence. They examine major healthcare venture funding rounds, the resurgence of biotech investment, Medicare policy changes, PBM scrutiny, rising healthcare spending driven by GLP-1 drugs, rural hospital transformation, chemotherapy drug shortages, new cancer treatments, and the growing use of Wegovy in children. The episode also covers Bitcoin's sharp decline, venture capital consolidation, and the future of healthcare innovation.

Story Lineup

1 — In This Economy

1:59 - Story 1: PCE Hits 4.1% — The Iran War, the...

Marcus welcomes Ash Shehata, former KPMG executive and current Impact Advisors leader, as guest host for a wide-ranging discussion on healthcare, technology, finance, and policy. They examine the Federal Reserve’s evolving approach under Kevin Warsh, the economic implications of reopening the Strait of Hormuz, and SpaceX’s historic IPO alongside its reported Cursor acquisition. The conversation also covers the resurgence of biotech and pharmaceutical M&A, FDA flexibility around gene therapies, rural hospital transformation funding, information blocking enforcement, Medicare Advantage contract disputes, PBM transparency battles, smart hospital rooms, longevity medicine, GLP-1 coverage expansion for seniors, digital assets, tokenized stoc...

Vic and Marcus discuss rising inflation tied to escalating conflict in Iran and the broader economic implications for energy markets, review major venture capital and healthcare startup funding activity including surgical AI company Uncovr, examine developments in AI adoption and productivity across healthcare, analyze the competitive landscape between Apple and leading AI labs, explore IPO activity ranging from SpaceX demand to healthcare and pharmaceutical offerings, and close with a discussion on robotics, automation, and the impact of humanoid robots on future labor markets.

Links

Story 1: Economy

5:16 - Inflation Jumps as Iran War Intensifies...

Vic and Marcus discuss signs of stress in the private credit market, including redemption pressure at Blackstone, major healthcare and AI funding rounds, and the growing interest of technology investors in longevity startups. They examine legal and regulatory developments involving generic drug marketing, Massachusetts' lawsuit against UnitedHealthcare over alleged Medicaid fraud, and California's action related to the 23andMe data breach. The conversation also covers health system adoption of artificial intelligence through partnerships with General Catalyst, new healthcare AI investments, the evolving IPO market, and growing debate over AI regulation and the role of companies such as Anthropic, Google, and...

Vic and guest host Emily Evans discuss declining consumer sentiment, challenges in the labor market, and the growing impact of AI on jobs and small businesses. They examine FDA food regulation and the debate around "generally regarded as safe" ingredients, Medicaid policy changes and fraud enforcement efforts under CMS, the expansion of AI from large enterprises to Main Street businesses, concerns that GLP-1 weight loss drugs may contribute to muscle loss and frailty, and major developments in the AI infrastructure race, including Amazon's multibillion-dollar chip deal.

Links

Story 1: Economy

00:41 - U.S. Consumer...

Vic and Marcus sit down with Chris Boone, Group Vice President of Research Services at Oracle Health and Life Sciences, live from the Jumpstart Health Summit. The conversation explores Oracle’s growing role in healthcare following its Cerner acquisition, the future of real world evidence in drug discovery, how artificial intelligence is reshaping clinical research and healthcare organizations, and the opportunities and challenges surrounding AI adoption, regulation, workforce transformation, and precision medicine. They also discuss predictive healthcare, autonomous agents, the evolution of healthcare leadership, and what a world free of disease could realistically look like.

Vic and Marcus discuss rising inflation driven by energy costs and the impact on consumers, travel, and wage growth. They examine newly confirmed Fed Chair Kevin Warsh and debate whether AI investment and market enthusiasm are creating an economic bubble. The episode covers healthcare job growth becoming a key driver of California’s economy, major healthcare venture funding activity, and the resignation of FDA Commissioner Marty Makary and what it could signal about the future of regulation. Additional topics include declining overdose deaths, changes to PBMs after Optum Rx moves to a fee-based model, Hims & Hers struggling after the GL...

Vic and Marcus discuss the latest signals from the labor market and growing concerns around AI-driven layoffs, including workforce cuts at Coinbase, PayPal, and other major companies. They examine how AI is reshaping healthcare operations, payer strategies, and pharmaceutical distribution, with conversations covering IBM and OpenAI’s work with Elevance, Hims & Hers launching AI lab interpretation tools, Google’s push into consumer health, and Roche acquiring PathAI. The episode also covers RFK Jr.’s push to reduce antidepressant use, the SEC proposal to eliminate quarterly reporting, CVS and Oscar Health earnings, UPMC acquiring CommonSpirit’s Trinity Health assets, renewed momentum...

Vic and Marcus cover Jerome Powell remaining on the Federal Reserve board and concerns around Fed independence, global instability including the UAE exiting OPEC and weakening international institutions, and hyperscaler dominance with strong earnings from Google, Amazon, and Microsoft driven by AI and cloud growth; they discuss venture funding trends including brain-computer interfaces and clinical AI models, FDA adoption of AI to accelerate clinical trials, and policy shifts including the withdrawal of Casey Means’ nomination and Cigna exiting ACA markets; the episode also explores payer performance, Humana’s partnership with Mark Cuban’s Cost Plus Drugs, pharma consolidation led by Eli...

Vic and Marcus recap insights from the Health Evolution Summit, focusing on high-value networking versus weak conference content, then break down major economic and policy developments including Kevin Warsh’s expected appointment as Fed Chair, the end of the investigation into Jerome Powell, and shifts in Fed governance. They cover venture activity across AI healthcare, biotech resurgence, and crowded revenue cycle startups, alongside new accelerators backed by Anne Wojcicki. Policy wins include FDA gene therapy breakthroughs, marijuana reclassification, and faster CMS coverage pathways. The episode dives into payer performance with improved MLR trends, ongoing health system struggles, and biotech de...

Vic and Marcus break down a surge in AI development, starting with Vic’s hands-on experience building autonomous agents and what it reveals about the future of work, productivity, and identity. They discuss the growing gap between economic growth and job creation, the psychological impact of AI on workers, and parallels to past industry disruptions. The episode covers venture activity in healthcare, including AI-native operating systems, fertility innovation, and value-based care startups, alongside policy updates like digital health reimbursement models and system-wide labor tensions. They examine the expanding role of GLP-1 drugs beyond weight loss, major pharma momentum, and th...

Vic and Marcus break down revised GDP data and slowing economic growth, rising concerns around private credit exposure across banks and pensions, and the long-term decline in labor force participation driven by aging demographics and immigration policy. They discuss the evolving job market as AI creates new roles and skill demands, while also examining venture activity including Yuzu Health’s funding and broader digital health investment trends. The episode covers major healthcare policy shifts like Medicare Advantage rate changes, California’s stance on private equity in medical practices, and health system performance driven by scale. They also explore breakthroughs in o...

Vic and Marcus recap the Jumpstart Health Summit, including a workshop where non-technical founders built full AI-driven products and an agentic investment bank in under 48 hours, followed by key discussions from the summit on healthcare transformation, AI infrastructure, venture capital evolution, and leadership changes at Jumpstart Health. They break down major economic signals including declining job openings, stock market performance, and rising risks in private credit markets, then analyze healthcare policy shifts targeting hospital pricing practices and UnitedHealthcare’s push into AI-driven member tools. The episode also covers major pharma momentum led by Eli Lilly across acquisitions, GLP-1 advancements, an...

Vic and Marcus discuss rising energy costs and their ripple effects across the economy, declining tourism, and ongoing financial pressure tied to global instability. They break down major healthcare funding deals including telehealth weight loss platforms and AI governance in health systems, along with payer struggles and pharmaceutical acquisitions. The episode explores legal shifts around social media liability and Section 230, contrasting platform responsibility with internet infrastructure. They cover policy updates in Medicaid and rural hospital funding, trends in tokenized financial markets, and AI developments across healthcare, enterprise, and consumer platforms. The conversation closes with a deep dive into the...

Vic and Emily Evans discuss the Fed holding rates and the declining influence of monetary policy, Turquoise Health’s $40M raise and the shift toward payment infrastructure, and the broader slowdown in healthcare spending growth. They explore consumer-driven healthcare models, political tensions around insurance and affordability, and upcoming policy shifts. The episode also covers vaccine policy changes, cancer immunotherapy efforts, CMS’s new wearable-driven care model, the rise of ketamine prescriptions, crypto regulation clarity, tokenized markets, AI’s expanding role in healthcare and business, and the growing challenge of trust in an era of synthetic media.

Links

S...

Vic and Marcus discuss the latest macro forces shaping healthcare and technology, starting with inflation trends, rising oil prices, and how geopolitical tensions involving Iran could impact global markets and supply chains. They examine how healthcare has become the primary driver of U.S. job growth while questioning whether the industry can sustain the broader labor market long term. The conversation covers venture funding activity including AI healthcare startups, maternal health investments, and the growing debate over massive venture rounds in the AI era. They also analyze major industry developments such as CVS and Aetna resolving Medicare Advantage investigations...

Marcus and Vic break down a turbulent week across geopolitics, markets, technology, and healthcare, starting with escalating conflict involving Iran and the economic volatility rippling through global markets. They examine rising uncertainty in the economy, the growing push for European tech independence from U.S. platforms, and how reliability concerns are driving companies toward self-hosted AI models. The conversation moves into financial risk as private credit giants like Blackstone face redemption pressure, the legal chaos surrounding $130B in tariff refunds, and several major healthcare venture deals including Sage, Third Way Health, KeyCare, and Grow Therapy. They also explore policy...

Vic and Marcus unpack a chaotic week across AI, markets, healthcare, and crypto. They begin with a viral Substack post outlining a “2028 Global Intelligence Crisis” that triggered market volatility and reignited debate over mass white-collar job displacement. They examine Block’s decision to cut more than 40% of its workforce amid AI-driven efficiency gains and debate whether entrepreneurship will replace traditional employment. The conversation moves through new AI startups transforming medtech sales and credentialing, automation in healthcare front offices and pathology, and escalating Medicaid and ACA policy shifts that could impact deductibles and medical debt. They discuss ongoing GLP-1 coverage battle...

In this episode of Health Further, hosts Vic and Marcus discuss the latest healthcare VC activity including Daffodil Health’s $16.3M raise for AI claims automation and Anterior’s $40M round accelerating AI adoption in health plans, followed by a deep dive into leadership shakeups at HHS, the resignation of a top FDA scientist amid concerns about political influence, and RFK Jr.’s continued restructuring at the CDC. They examine the rollout of the CMMI Access Model and what it signals about AI-first and tech-enabled care in rural America, review financial turnarounds at Community Health Systems, CommonSpirit, and Ascension, unpack...

Vic and Marcus break down January’s unexpected jobs uptick and why healthcare continues to dominate employment growth while capital outpaces labor across the broader economy. They analyze record market caps for major tech companies, the widening gap between corporate earnings and wages, and what that means for the future workforce. The episode explores two unicorn care navigation startups taking opposite approaches, new ACA policy shifts expanding non-standard plan options, and accelerating interoperability through TEFCA. They unpack the 340B rebate battle, mounting rural hospital closures, robotics in maternity care, Humana’s aggressive Medicare Advantage growth strategy, payer layoffs and rest...

In this episode, Vic and Marcus break down a sharp tech stock selloff driven by AI disruption, examine how AI is reshaping software, venture capital, and healthcare operations, and discuss major funding rounds in cardiology and women’s health. They analyze sweeping healthcare policy moves from the Trump administration, including drug pricing, PBM reform, telehealth expansion, and changes to addiction recovery funding. The conversation also covers payer performance with a focus on Cigna, winners and losers in pharma earnings, ongoing nursing workforce strain, Epic and Optum’s expanding AI tools, and the risks and realities of autonomous AI agents as n...

Vic and Marcus break down the ripple effects of a major winter storm in Nashville before covering a wide range of healthcare and tech developments, including rising ACA premiums as subsidies expire, corporate layoffs and their impact on insurance markets, venture funding for virtual autism therapy, Medicare Advantage rate pressure, insurer earnings declines, strong performance from major health systems, the growth of direct-to-consumer healthcare brands, Amazon and One Medical’s expansion into at-home diagnostics, consolidation in employer-sponsored primary care, the long-term realities of GLP-1 weight loss drugs, new FDA-approved treatments for presbyopia, Tether’s aggressive gold accumulation strategy, rapid adva...

Vic hosts a solo episode covering volatility in the stock market tied to geopolitical tensions, a detailed breakdown of 2025 inflation data and how price increases vary by consumer category, congressional movement on healthcare funding and PBM reform, proposed multi-year extensions for telehealth and hospital-at-home programs, ARPA-H’s call for AI-driven cardiovascular care solutions, UnitedHealthcare’s plan to rebate ACA profits to members, the New York Stock Exchange’s move toward tokenized 24/7 trading, Amazon’s launch of an AI health assistant for One Medical members, and new survey data revealing a widening gap between how executives and workers experience productivity gains fr...